1. Home
  2. DCTH vs VLGEA Comparison

DCTH vs VLGEA Comparison

Compare DCTH & VLGEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • VLGEA
  • Stock Information
  • Founded
  • DCTH 1988
  • VLGEA 1937
  • Country
  • DCTH United States
  • VLGEA United States
  • Employees
  • DCTH N/A
  • VLGEA N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • VLGEA Food Chains
  • Sector
  • DCTH Health Care
  • VLGEA Consumer Staples
  • Exchange
  • DCTH Nasdaq
  • VLGEA Nasdaq
  • Market Cap
  • DCTH 630.4M
  • VLGEA 532.5M
  • IPO Year
  • DCTH N/A
  • VLGEA N/A
  • Fundamental
  • Price
  • DCTH $16.30
  • VLGEA $38.64
  • Analyst Decision
  • DCTH Strong Buy
  • VLGEA
  • Analyst Count
  • DCTH 4
  • VLGEA 0
  • Target Price
  • DCTH $24.00
  • VLGEA N/A
  • AVG Volume (30 Days)
  • DCTH 610.5K
  • VLGEA 34.7K
  • Earning Date
  • DCTH 05-08-2025
  • VLGEA 06-10-2025
  • Dividend Yield
  • DCTH N/A
  • VLGEA 2.60%
  • EPS Growth
  • DCTH N/A
  • VLGEA 3.71
  • EPS
  • DCTH N/A
  • VLGEA 3.65
  • Revenue
  • DCTH $53,850,000.00
  • VLGEA $2,281,980,000.00
  • Revenue This Year
  • DCTH $141.47
  • VLGEA N/A
  • Revenue Next Year
  • DCTH $49.31
  • VLGEA N/A
  • P/E Ratio
  • DCTH N/A
  • VLGEA $10.57
  • Revenue Growth
  • DCTH 1068.87
  • VLGEA 3.96
  • 52 Week Low
  • DCTH $6.33
  • VLGEA $24.57
  • 52 Week High
  • DCTH $18.23
  • VLGEA $39.17
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 58.68
  • VLGEA 64.84
  • Support Level
  • DCTH $15.73
  • VLGEA $37.65
  • Resistance Level
  • DCTH $17.29
  • VLGEA $39.17
  • Average True Range (ATR)
  • DCTH 0.96
  • VLGEA 1.05
  • MACD
  • DCTH -0.08
  • VLGEA 0.19
  • Stochastic Oscillator
  • DCTH 50.58
  • VLGEA 85.75

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About VLGEA Village Super Market Inc.

Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.

Share on Social Networks: